Michael O’Meara

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials

Brian K. Albrecht, Victor Gehling, Michael C. Hewitt et al. · Journal of Medicinal Chemistry · 2016 · 215 citations · Full text

Medicine, Oncology, Pharmacology +15

Acute cocaine poisoning

Steinn Jónsson, Michael O’Meara, James B. Young · The American Journal of Medicine · 1983 · 170 citations

Brief Report: A phase IIa, randomized, double‐blind, placebo‐controlled trial of apilimod mesylate, an interleukin‐12/interleukin‐23 inhibitor, in patients with rheumatoid arthritis

Sarah Krausz, Maria J H Boumans, Daniëlle M. Gerlag et al. · Arthritis & Rheumatism · 2011 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +16

BET Inhibitor CPI-0610 Is Well Tolerated and Induces Responses in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma: Preliminary Analysis of an Ongoing Phase 1 Study

Jeremy S. Abramson, Kristie A. Blum, Ian W. Flinn et al. · Blood · 2015 · 61 citations

Medicine, Hematology, Oncology +10

Uterine fibroids increase the risk of hypertensive disorders of pregnancy: a prospective cohort study

Yequn Chen, Mengyue Lin, Pi Guo et al. · Journal of Hypertension · 2020 · 43 citations · Full text

Public Health, Maternal Health, Obstetrics +17